May 13, 2026 04:10PM
May 13, 2026 06:51AM
May 7, 2026 06:06AM
Mar 16, 2026 12:41PM
Mar 16, 2026 09:00AM
Feb 18, 2026 08:02AM
Feb 12, 2026 08:30AM Aprea Therapeutics expands patent portfolio for cancer drugs through 2045
Feb 4, 2026 08:32AM
Jan 29, 2026 08:29AM
Dec 19, 2025 04:13PM
Dec 18, 2025 08:33AM
Nov 12, 2025 04:28PM
Oct 24, 2025 08:31AM
Aug 12, 2025 08:29AM Aprea Therapeutics (APRE) Misses Q2 EPS by 53c
May 14, 2025 04:37PM
Apr 17, 2025 07:01AM
Mar 25, 2025 04:22PM
Mar 11, 2025 08:32AM
Feb 5, 2025 08:01AM
Jan 16, 2025 06:53AM
Oct 23, 2024 08:31AM Aprea Therapeutics (APRE) Presents Preliminary Findings on Oral WEE1 Inhibitor APR-1051 at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics

396,364 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All